Oragenics Inc. Files 2024 Annual Report

Ticker: OGEN · Form: 10-K · Filed: Mar 14, 2025 · CIK: 1174940

Sentiment: neutral

Topics: 10-K, annual-report, pharmaceuticals

TL;DR

Oragenics filed its 2024 10-K. Full financials and biz ops detailed.

AI Summary

Oragenics Inc. filed its 10-K for the fiscal year ending December 31, 2024, reporting its financial position and business operations. The company, headquartered in Sarasota, Florida, operates in the pharmaceutical preparations sector. Key financial data and operational details for the fiscal years 2024, 2023, and 2022 are presented within this comprehensive filing.

Why It Matters

This 10-K filing provides investors and stakeholders with a detailed overview of Oragenics Inc.'s financial health and strategic direction for the past fiscal year, crucial for investment decisions.

Risk Assessment

Risk Level: medium — As a pharmaceutical company, Oragenics faces inherent risks related to drug development, regulatory approvals, and market competition.

Key Numbers

Key Players & Entities

FAQ

What is Oragenics Inc.'s primary business activity?

Oragenics Inc. operates in the Pharmaceutical Preparations sector, as indicated by its Standard Industrial Classification code 2834.

When was this 10-K filing submitted to the SEC?

This 10-K filing was submitted on March 14, 2025.

Where is Oragenics Inc. headquartered?

Oragenics Inc. is headquartered at 1990 Main Street, Suite 750, Sarasota, Florida, 34236.

What fiscal year does this 10-K report cover?

This 10-K report covers the fiscal year ending December 31, 2024.

What are the SIC and SEC file numbers for Oragenics Inc.?

The Standard Industrial Classification (SIC) is 2834, and the SEC file number is 001-32188.

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on March 14, 2025 regarding ORAGENICS INC (OGEN).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR

View on Read The Filing